Back to state act
Description
On 2 April 2026, the U.S. Administration issued a proclamation imposing Section 232 tariffs on imported patented pharmaceuticals and associated pharmaceutical ingredients. As part of this proclamation...
Sign in to see full description
Intervention Details
Intervention Type
Import tariff
MAST Chapter
FDI measures
Implementation date
No implementation date
Revocation date
No revocation date
Implementation level
National
Affected flow
Inward
Announced as temporary
No
Eligible firms
all
Affected Trading Partners
Table
Affected Sectors
Sign in to access 2 sectors
Affected Products
Sign in to access 180 products
Threads
See all
This intervention is not part of any Thread yet.